# Amplification and Selection of Antimicrobial Resistance in the Intestine II

> **NCT03140826** · — · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 60 (actual)

## Conditions studied

- Antibiotic Selection Pressure

## Interventions

- **DRUG:** meropenem

## Key facts

- **NCT ID:** NCT03140826
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140826, "Amplification and Selection of Antimicrobial Resistance in the Intestine II". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03140826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*